RBC Capital Reiterates Outperform Rating on Ardent Health Partners, LLC (ARDT)

Market Context

Ardent Health Partners, LLC operates in the Healthcare sector. The stock currently trades at $10.09 with a market capitalization of $1.3B. The stock has declined 26.7% over the past 52 weeks.

Analyst coverage from RBC Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Ardent Health Partners, LLC.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Ardent Health Partners, LLC

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 09, 2026	RBC Capital	Outperform	N/A
May 07, 2026	UBS	Buy	N/A
Mar 10, 2026	RBC Capital	Outperform	N/A
Mar 06, 2026	Leerink Partners	Outperform	N/A
Jan 20, 2026	JP Morgan	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View ARDT Stock Page